,i #aaith ,,congress #ast ,session ,h4 ,r4 #bcjj ,,in ,,the ,,house ,,of ,,representatives ,march #bd1 #bjbe,mrs4 ,harshbarger 7for herself and ,mr4 ,schneider7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to ensure national uniformity with respect to certain requirements relating to preterm infant formula1 and for other purposes4 #a4 ,preterm infant formula 7a7 ,study 7#a7 ,in general ,the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 shall study-- 7,a7 the availability of preterm infant formula in the ,united ,states2 7,b7 ,federal and ,state laws1 regulations1 orders1 and requirements1 including under ,state common law1 that relate to preterm infant formula1 including with respect to-- 7i7 the design1 development1 clinical testing or investigation1 formulation1 manufacture1 distribution1 sale1 donation1 purchase1 marketing1 promotion1 packaging1 labeling1 licensing1 and use of preterm infant formula2 or 7ii7 any aspect of the safety of preterm infant formula2 7,c7 whether the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cja et seq47 should be amended to require a manufacturer of preterm infant formula to obtain premarket approval for such formula from the ,food and ,drug ,administration2 and 7,d7 if the ,secretary recommends such premarket approval1 a process and corresponding requirements for such premarket approval4 7#b7 ,recommendations ,not later than two years after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 shall submit to the ,congress a report on the results of the study under paragraph 7#a74 7b7 ,temporary preemption 7#a7 ,period of applicability ,this subsection applies only during the period-- 7,a7 beginning on the date of enactment of this ,act2 and 7,b7 ending on the date that is two years after the date of enactment of this ,act4 7#b7 ,preemption ,except as provided in paragraph 7#c71 no ,state or political subdivision of a ,state may establish1 implement1 or enforce with respect to preterm infant formula any requirement1 including under any ,state statute1 regulation1 order1 or common law-- 7,a7 that is different from1 or in addition to1 any requirement applicable to preterm infant formula under the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cja et seq471 the ,poison ,prevention ,packaging ,act of #aigj 7#ae ,u4,s4,c4 #adga et seq471 or the ,fair ,packaging and ,labeling ,act 7#ae ,u4,s4,c4 #adea et seq472 and 7,b7 that relates to preterm infant formula1 including-- 7i7 the design1 development1 clinical testing or investigation1 formulation1 manufacture1 distribution1 sale1 donation1 purchase1 marketing1 promotion1 packaging1 labeling1 licensing1 and use of preterm infant formula2 and 7ii7 any aspect of the safety of preterm infant formula4 7#c7 ,exception for civil and criminal actions for willful misconduct 7,a7 ,exception ,paragraph 7#b7 does not preempt civil or criminal actions based on a requirement described in paragraph 7#b7 to the extent such actions are against a manufacturer for willful misconduct in the manufacturing or production of preterm infant formula that caused death or serious physical injury4 7,b7 ,removal ,in the case of a civil action brought in a ,state court against a manufacturer1 if that manufacturer alleges that the law under which the action is brought is preempted by paragraph 7#b71 such action may be removed by the manufacturer to the district court of the ,united ,states for the district and division embracing the place wherein the civil action is pending4 ,this subparagraph applies to any action pending before1 on1 or after the date of enactment of this ,act1 except to the extent that there is a final judgment from which no appeal may be taken and no further review may be sought from a court of last resort1 including the ,supreme ,court of the ,united ,states4 7,c7 ,burden of proof ,in determining whether the exception in subparagraph 7,a7 applies1 the plaintiff shall have the burden of proving that the criteria described in subparagraph 7,a7 are met by clear and convincing evidence4 7#d7 ,dismissal of pending actions ,a civil or criminal action that is pending as of the date of enactment of this ,act shall be dismissed to the extent such action seeks to implement or enforce a requirement that is preempted by paragraph 7#b74 7c7 ,definitions ,in this section3 7#a7 ,the term infant formula has the meaning given to such term in section #bja7z7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cba7z774 7#b7 ,the term manufacturer-- 7,a7 means a person who-- 7i7 prepares1 reconstitutes1 or otherwise changes the physical or chemical characteristics of a preterm infant formula2 or 7ii7 packages or labels a preterm infant formula in a container for distribution2 and 7,b7 does not include a person taking actions described in subparagraph 7,a7 exclusively for an infant under such person's direct care4 7#c7 ,the term preterm infant formula means any infant formula that is exempt under section #dab7;h77#a7 of the ,federal ,food ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cej;a7h77 and intended to be administered to-- 7,a7 an infant born before #cg weeks of gestation2 or 7,b7 a low-birth-weight infant4 7#d7 ,the term willful misconduct means1 except as such term is further restricted pursuant to subparagraph 7,b71 an act or omission that is taken-- 7,a7 intentionally to achieve a wrongful purpose2 7,b7 knowingly without legal or factual justification2 and 7,c7 in disregard of a known or obvious risk that is so great as to make it highly probable that the harm will outweigh the benefit4